Literature DB >> 19757488

A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers.

Taco G Uil1, Jeroen de Vrij, Jort Vellinga, Martijn J W E Rabelink, Steve J Cramer, On Ying A Chan, Margherita Pugnali, Maria Magnusson, Leif Lindholm, Pierre Boulanger, Rob C Hoeben.   

Abstract

BACKGROUND: Many studies aimed at retargeting adenovirus (Ad) rationally focus on genetic modification of fiber, which is the primary receptor-binding protein of Ad. Retargeted fibers ultimately require functional validation in the viral context.
METHODS: Lentiviral vectors (LV) were used to express fiber variants in cells. Infections with a fiber gene-deleted Ad vector yielded fiber-pseudotyped viruses. An enzyme-linked immunosorbent assay and slot blot-based assays probed target binding-ability of retargeted fibers. Differential treatments with an alkylating agent prior to western blot analysis allowed for examination of intra- and extracellular redox states of fibers.
RESULTS: In the present study, LV-based fiber-pseudotyping of Ad is presented as an accelerated means to test new fibers. LV-mediated gene transfer yielded stable and uniform populations of fiber variant-expressing cells. These populations were found to effectively support fiber-pseudotyping of Ad. As a secondary objective of the study, we functionally assessed a chimeric fiber harboring a tumor antigen-directed single-chain antibody fragment (scFv). This fiber was shown to trimerize and achieve a degree of binding to its antigenic target. However, its capsid incorporation ability was impaired and, moreover, it was unable to confer a detectable level of target binding upon Ad. Importantly, subsequent analyses of this fiber revealed the improper folding of its scFv constituent.
CONCLUSIONS: LV-based fiber-pseudotyping was established as a convenient method for testing modified fibers for functionality within Ad particles. Furthermore, a new chimeric fiber was found to be inadequate for Ad retargeting. The folding difficulties encountered for this particular fiber might be generally inherent to the use (i.e. for genetic Ad capsid incorporation) of complex, disulfide bridge-containing natural ligands.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757488     DOI: 10.1002/jgm.1395

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  4 in total

1.  Directed adenovirus evolution using engineered mutator viral polymerases.

Authors:  Taco G Uil; Jort Vellinga; Jeroen de Vrij; Sanne K van den Hengel; Martijn J W E Rabelink; Steve J Cramer; Julia J M Eekels; Yavuz Ariyurek; Michiel van Galen; Rob C Hoeben
Journal:  Nucleic Acids Res       Date:  2010-12-07       Impact factor: 16.971

2.  Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.

Authors:  Stéphanie Corjon; Gaëlle Gonzalez; Petra Henning; Alexei Grichine; Leif Lindholm; Pierre Boulanger; Pascal Fender; Saw-See Hong
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

3.  Development of a lentivirus vector-based assay for non-destructive monitoring of cell fusion activity.

Authors:  Zeinab Neshati; Jia Liu; Guangqian Zhou; Martin J Schalij; Antoine A F de Vries
Journal:  PLoS One       Date:  2014-07-16       Impact factor: 3.240

4.  Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors.

Authors:  Jeroen de Vrij; Sanne K van den Hengel; Taco G Uil; Danijela Koppers-Lalic; Iris J C Dautzenberg; Oscar M J A Stassen; Montserrat Bárcena; Masato Yamamoto; Corrina M A de Ridder; Robert Kraaij; Kitty M Kwappenberg; Marco W Schilham; Rob C Hoeben
Journal:  Virology       Date:  2010-12-04       Impact factor: 3.616

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.